CordovaCann Corp
CordovaCann Corp. engages in the provision of services and investment capital to the processing, production, and retail vertical markets of the cannabis industry in Canada and United States. The company was formerly known as LiveReel Media Corporation and changed its name to CordovaCann Corp. in January 2018. CordovaCann Corp. was founded in 1997 and is headquartered in Toronto, Canada.
CordovaCann Corp (LVRLF) - Net Assets
Latest net assets as of March 2024: $-2.19 Million USD
Based on the latest financial reports, CordovaCann Corp (LVRLF) has net assets worth $-2.19 Million USD as of March 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($9.79 Million) and total liabilities ($11.98 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-2.19 Million |
| % of Total Assets | -22.39% |
| Annual Growth Rate | N/A |
| 5-Year Change | -171.12% |
| 10-Year Change | N/A |
| Growth Volatility | 1922.54 |
CordovaCann Corp - Net Assets Trend (2004–2025)
This chart illustrates how CordovaCann Corp's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for CordovaCann Corp (2004–2025)
The table below shows the annual net assets of CordovaCann Corp from 2004 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-06-30 | $-5.21 Million | -100.42% |
| 2024-06-30 | $-2.60 Million | -152.82% |
| 2023-06-30 | $-1.03 Million | -115.60% |
| 2022-06-30 | $6.59 Million | -10.00% |
| 2021-06-30 | $7.32 Million | +16.60% |
| 2020-06-30 | $6.28 Million | +1631.17% |
| 2019-06-30 | $362.57K | -92.04% |
| 2018-06-30 | $4.56 Million | +827.13% |
| 2017-06-30 | $-626.48K | -16.43% |
| 2016-06-30 | $-538.07K | -15.87% |
| 2015-06-30 | $-464.36K | -29.71% |
| 2014-06-30 | $-357.99K | -54.19% |
| 2013-06-30 | $-232.17K | -11.52% |
| 2012-06-30 | $-208.19K | -221.06% |
| 2011-06-30 | $-64.84K | -151.61% |
| 2010-06-30 | $125.65K | -60.63% |
| 2009-06-30 | $319.18K | -73.44% |
| 2008-06-30 | $1.20 Million | -39.63% |
| 2007-06-30 | $1.99 Million | -21.15% |
| 2006-06-30 | $2.52 Million | +6578.61% |
| 2005-06-30 | $37.80K | +165.77% |
| 2004-06-30 | $-57.48K | -- |
Equity Component Analysis
This analysis shows how different components contribute to CordovaCann Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 4447820200.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (June 2025)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | $38.67 Million | % |
| Total Equity | $-5.81 Million | 100.00% |
CordovaCann Corp Competitors by Market Cap
The table below lists competitors of CordovaCann Corp ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Quantum Healthcare Limited
PINK:QTHLF
|
$2.42 Million |
|
Oceancash Pacific Bhd
KLSE:0049
|
$2.42 Million |
|
Golden Tobacco Limited
NSE:GOLDENTOBC
|
$2.42 Million |
|
Saigon General Service Corp
VN:SVC
|
$2.42 Million |
|
Lakshmi Finance & Industrial Corporation Limited
NSE:LFIC
|
$2.42 Million |
|
SIGNATURE RESOURCES NEW
F:3S30
|
$2.41 Million |
|
Applied DB Public Company Limited
BK:ADB
|
$2.41 Million |
|
TDG Global Investment JSC
VN:TDG
|
$2.41 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in CordovaCann Corp's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from -3,299,990 to -5,805,888, a change of -2,505,898.
- Net loss of 2,690,678 reduced equity.
- Other factors increased equity by 184,780.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-2.69 Million | -46.34% |
| Other Changes | $184.78K | +3.18% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares CordovaCann Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2004-06-30 | $-0.02 | $0.08 | x |
| 2005-06-30 | $0.00 | $0.08 | x |
| 2006-06-30 | $0.27 | $0.08 | x |
| 2007-06-30 | $0.14 | $0.08 | x |
| 2008-06-30 | $0.09 | $0.08 | x |
| 2009-06-30 | $0.02 | $0.08 | x |
| 2010-06-30 | $0.01 | $0.08 | x |
| 2011-06-30 | $0.00 | $0.08 | x |
| 2012-06-30 | $-0.01 | $0.08 | x |
| 2013-06-30 | $-0.01 | $0.08 | x |
| 2014-06-30 | $-0.02 | $0.08 | x |
| 2015-06-30 | $-0.02 | $0.08 | x |
| 2016-06-30 | $-0.02 | $0.08 | x |
| 2017-06-30 | $-0.03 | $0.08 | x |
| 2018-06-30 | $0.11 | $0.08 | x |
| 2019-06-30 | $0.01 | $0.08 | x |
| 2020-06-30 | $0.12 | $0.08 | x |
| 2021-06-30 | $0.08 | $0.08 | x |
| 2022-06-30 | $0.06 | $0.08 | x |
| 2023-06-30 | $-0.02 | $0.08 | x |
| 2024-06-30 | $-0.03 | $0.08 | x |
| 2025-06-30 | $-0.05 | $0.08 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently CordovaCann Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -18.88%
- • Asset Turnover: 2.22x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-151.41%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2004 | 0.00% | 0.00% | 0.00x | 0.00x | $-208.85K |
| 2005 | -686.53% | -5158.70% | 0.02x | 6.35x | $-263.31K |
| 2006 | -27.02% | -9672.39% | 0.00x | 1.05x | $-934.58K |
| 2007 | -31.38% | -859.31% | 0.03x | 1.06x | $-823.76K |
| 2008 | -65.63% | -1971.44% | 0.03x | 1.15x | $-909.00K |
| 2009 | -287.07% | -18695.37% | 0.01x | 1.29x | $-948.18K |
| 2010 | -185.06% | 0.00% | 0.00x | 1.46x | $-245.09K |
| 2011 | 0.00% | 0.00% | 0.00x | 0.00x | $-244.07K |
| 2012 | 0.00% | 0.00% | 0.00x | 0.00x | $-140.32K |
| 2013 | 0.00% | 0.00% | 0.00x | 0.00x | $3.53K |
| 2014 | 0.00% | 0.00% | 0.00x | 0.00x | $-90.02K |
| 2015 | 0.00% | 0.00% | 0.00x | 0.00x | $-59.93K |
| 2016 | 0.00% | 0.00% | 0.00x | 0.00x | $-19.90K |
| 2017 | 0.00% | 0.00% | 0.00x | 0.00x | $-25.76K |
| 2018 | -106.82% | 0.00% | 0.00x | 1.07x | $-5.32 Million |
| 2019 | -1716.47% | 0.00% | 0.00x | 12.81x | $-6.26 Million |
| 2020 | -82.78% | -2788.76% | 0.01x | 2.62x | $-5.21 Million |
| 2021 | -73.73% | -46.39% | 0.60x | 2.66x | $-5.44 Million |
| 2022 | -68.64% | -29.75% | 0.81x | 2.86x | $-4.61 Million |
| 2023 | 0.00% | -50.64% | 1.32x | 0.00x | $-6.71 Million |
| 2024 | 0.00% | -10.82% | 1.44x | 0.00x | $-1.16 Million |
| 2025 | 0.00% | -18.88% | 2.22x | 0.00x | $-2.11 Million |
Industry Comparison
This section compares CordovaCann Corp's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $439,452,927
- Average return on equity (ROE) among peers: -31.68%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| CordovaCann Corp (LVRLF) | $-2.19 Million | 0.00% | N/A | $2.42 Million |
| Ascend Wellness Holdings Inc (AAWH) | $71.80 Million | -118.37% | 11.54x | $48.90 Million |
| AB Science S.A (ABSCF) | $-21.01 Million | 0.00% | 0.00x | $39.89 Million |
| Alterola Biotech Inc (ABTI) | $-294.68K | 0.00% | 0.00x | $603.58K |
| Aurora Cannabis Inc (ACB) | $521.74 Million | -156.52% | 0.78x | $195.20 Million |
| Acreage Holdings Inc (ACRDF) | $494.79 Million | -30.37% | 0.40x | $13.48K |
| Acura Pharmaceuticals Inc (ACUR) | $29.91 Million | 0.00% | 0.07x | $13.20K |
| Agra Ventures Ltd. (AGFAF) | $1.72 Million | -18.78% | 0.11x | $298.23K |
| Allergy Therapeutics plc (AGYTF) | $20.08 Million | -10.91% | 0.33x | $25.30 Million |
| Aida Pharmaceuticals Inc (AIDA) | $21.19 Million | 12.93% | 1.96x | $1.85 |
| Adcock Ingram Holdings Limited (AIHLF) | $3.25 Billion | 5.19% | 0.72x | $85.61 Million |